Cephalexin
Product Images NDC 73614-202

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 73614-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Brisk Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Box (Orapaz Box)

ORAPAZ packaging label for Cephalexin Capsules USP 500 mg, Ibuprofen Tablets USP 800 mg, and Chlorhexidine Gluconate Oral Rinse USP 0.12%. The label indicates a 30 count bottle for capsules and tablets and two 118 ml bottles for oral rinse. Labeler is Brisk Pharmaceuticals. NDC 73614-417-03 is shown, along with storage instruction and manufacturer details.*

FDA Label Image

Ceph (Cephalexin Bottle)

Cephalexin Capsules USP 500 mg label displaying the product name, dosage strength, and form. The label indicates it is repackaged by Brisk Pharmaceuticals. The design includes green and black text on a white background with additional information about distribution and a barcode.*

FDA Label Image

Chlorhex (Chlorhex Bottle Green)

A drug information label for Chlorhexidine Gluconate Oral Rinse USP 0.12%, including ingredients, usage directions, storage instructions, and repackaging details. The label specifies the volume as 118 ml and notes distribution by Brisk Pharmaceuticals. Directions advise swishing undiluted for 30 seconds before spitting out.*

FDA Label Image

Ibu (Ibu Bottle Green)

Packaging label for Ibuprofen Tablets, USP 800 mg, containing 30 film-coated tablets. The label includes storage instructions to keep the product at 20°C to 25°C (68°F to 77°F) and notes it is repackaged by Unit Dose Solutions Inc. and distributed by Brisk Pharmaceuticals. The label also states the medication is for Rx use only and intended for distribution as part of an ORAPAZ pack.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.